Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Scotland
30 April 2013 11:43


Exclusive vacancies may not be shown here, please contact Ben on +44 1494 818005 or Ben@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Ben Chadwick
Team Leader
Ben@zenopa.com
+44 1494 818005

Testimonials
In my search for a new position within the pharma industry I found Zenopa's focused and tailored approach to be exactly what I needed to find the job I was looking for.
Brendan, 2011

Novartis becomes majority owner of Alcon

26 August 2010 00:00 in Pharmaceutical Company Restructures


Novartis has completed its purchase of 156 million shares in fellow pharmaceutical company Alcon, becoming the firm's majority shareholder in the process.

The company has paid a total of $28.3 billion (18.2 billion pounds) in cash to purchase shares previously owned by Nestle, meaning that Novartis now controls 77 per cent of Alcon's outstanding shares.

As a consequence of this move, five Nestle-designated members of Alcon's board of directors have stepped down from their positions and will be replaced by new members specified by Novartis.

Kevin Buehler, Alcon's president and chief executive officer, thanked Nestle for its contributions to the company's business for more than 30 years, while expressing confidence that its new relationship with Novartis will lead to further growth.

The sentiment was echoed by Joseph Jimenez, chief executive of Novartis, who stated: "Together, both companies can achieve their strategic priorities to deliver against patient needs through innovative and differentiated products."ADNFCR-8000103-ID-800040888-ADNFCR

Other news stories from 26/08/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd